Preview Mode Links will not work in preview mode
  1. All Episodes
  2. 2024
  3. 01

Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series

Jan 24, 2024

Featuring perspectives from Dr Antonio González-Martín, including the following topics:

  • Introduction: Treatment-Related Second Cancers (0:00)
  • Case: A woman in her mid 40s (gBRCA) who presents with ascites and is diagnosed with high-grade serous ovarian cancer (HGSOC) with extensive peritoneal disease — Lyndsay J...

Read More

Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series

Jan 17, 2024

Featuring perspectives from Dr Richard M Stone, including the following topics: 
• Introduction: ASH 2023 Update — Key Oral Presentations (0:00)
• Case: A woman in her early 90s with dementia who presented with anemia and was diagnosed with low-risk myelodysplastic syndromes (MDS) with ring sideroblasts, now...

Read More

Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma

Jan 10, 2024

Featuring perspectives from Dr Amrita Krishnan, Dr Sagar Lonial, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson, including the following topics: 
 
• Introduction (0:00)
• Management of Newly Diagnosed Multiple Myeloma (MM) — Dr Richardson (4:47)
• Integration of Novel Therapies into the...

Read More

Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma

Jan 8, 2024

Featuring perspectives from Prof Michael Dickinson, Prof Grzegorz S Nowakowski, Prof Gilles Salles, Dr Laurie H Sehn and Dr Jason Westin, including the following topics: 
 
• Introduction (0:00)
• Up-Front Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Salles (6:58)
• Promising Investigational...

Read More

HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer

Jan 4, 2024

Featuring perspectives from Dr Aditya Bardia, Dr Lisa A Carey, Dr Shanu Modi and Prof Peter Schmid, including the following topics: 
 
• Introduction (0:00)
• Optimal Approaches to HER2 Testing for the Identification of HER2-Low Breast Cancer — Dr Carey (3:27)
• Available Data with and Current Role of...

Read More